296 related articles for article (PubMed ID: 29077949)
1. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.
Pang KM; Castanotto D; Li H; Scherer L; Rossi JJ
Nucleic Acids Res; 2018 Jan; 46(1):e6. PubMed ID: 29077949
[TBL] [Abstract][Full Text] [Related]
2. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
[TBL] [Abstract][Full Text] [Related]
3. Small RNAs to treat human immunodeficiency virus type 1 infection by gene therapy.
Goguen RP; Malard CM; Scarborough RJ; Gatignol A
Curr Opin Virol; 2019 Oct; 38():10-20. PubMed ID: 31112858
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
5. Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration.
Nishitsuji H; Kohara M; Kannagi M; Masuda T
J Virol; 2006 Aug; 80(15):7658-66. PubMed ID: 16840344
[TBL] [Abstract][Full Text] [Related]
6. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 inactivation by nucleic acid aptamers.
Held DM; Kissel JD; Patterson JT; Nickens DG; Burke DH
Front Biosci; 2006 Jan; 11():89-112. PubMed ID: 16146716
[TBL] [Abstract][Full Text] [Related]
8. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.
Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ
Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872
[TBL] [Abstract][Full Text] [Related]
9. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
[TBL] [Abstract][Full Text] [Related]
10. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
von Eije KJ; ter Brake O; Berkhout B
J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
[TBL] [Abstract][Full Text] [Related]
11. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.
Chaloin L; Lehmann MJ; Sczakiel G; Restle T
Nucleic Acids Res; 2002 Sep; 30(18):4001-8. PubMed ID: 12235384
[TBL] [Abstract][Full Text] [Related]
12. The impact of unprotected T cells in RNAi-based gene therapy for HIV-AIDS.
Herrera-Carrillo E; Liu YP; Berkhout B
Mol Ther; 2014 Mar; 22(3):596-606. PubMed ID: 24336172
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
14. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells.
Zhou J; Swiderski P; Li H; Zhang J; Neff CP; Akkina R; Rossi JJ
Nucleic Acids Res; 2009 May; 37(9):3094-109. PubMed ID: 19304999
[TBL] [Abstract][Full Text] [Related]
15. Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex.
Van Melckebeke H; Devany M; Di Primo C; Beaurain F; Toulmé JJ; Bryce DL; Boisbouvier J
Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9210-5. PubMed ID: 18607001
[TBL] [Abstract][Full Text] [Related]
16. RNA-protein interactions govern antiviral specificity and encapsidation of broad spectrum anti-HIV reverse transcriptase aptamers.
Lange MJ; Nguyen PDM; Callaway MK; Johnson MC; Burke DH
Nucleic Acids Res; 2017 Jun; 45(10):6087-6097. PubMed ID: 28334941
[TBL] [Abstract][Full Text] [Related]
17. Selection of 2'-Deoxy-2'-Fluoroarabino Nucleic Acid (FANA) Aptamers That Bind HIV-1 Integrase with Picomolar Affinity.
Rose KM; Alves Ferreira-Bravo I; Li M; Craigie R; Ditzler MA; Holliger P; DeStefano JJ
ACS Chem Biol; 2019 Oct; 14(10):2166-2175. PubMed ID: 31560515
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-targeted RNAi for HIV-1 therapy.
Zhou J; Rossi JJ
Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-siRNA chimeras for HIV.
Takahashi M; Burnett JC; Rossi JJ
Adv Exp Med Biol; 2015; 848():211-34. PubMed ID: 25757623
[TBL] [Abstract][Full Text] [Related]
20. Exploring the binding of d(GGGT)4 to the HIV-1 integrase: An approach to investigate G-quadruplex aptamer/target protein interactions.
Esposito V; Pirone L; Mayol L; Pedone E; Virgilio A; Galeone A
Biochimie; 2016 Aug; 127():19-22. PubMed ID: 27109379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
